Literature DB >> 17537091

Clinical factors associated with prescription of a prosthetic limb in elderly veterans.

Jibby E Kurichi1, Pui L Kwong, Dean M Reker, Barbara E Bates, Clifford R Marshall, Margaret G Stineman.   

Abstract

OBJECTIVES: To determine how advanced age influences prosthetic prescription.
DESIGN: Retrospective cohort analysis with theory-driven logistic regression models. A Post Amputation Quality-of-Life (PAQ) framework of outcomes was proposed and empirically tested.
SETTING: Veterans Affairs Medical Centers. PARTICIPANTS: Two thousand three hundred seventy-five veterans with lower extremity amputations discharged between October 1, 2002, and September 30, 2003. MEASUREMENTS: Prosthetic prescription within 1 year of amputation.
RESULTS: Patients younger than 76 were 4.5 times as likely to receive a prescription compared to those aged 86 and older (odds ratio=4.51, 95% confidence interval=1.36-14.99) after controlling for sex, marital status, living circumstance before hospitalization, anatomical level, etiologies, comorbidities, medical acuity, and initial functional status. Patients admitted from extended care and patients with peripheral vascular disease, systemic sepsis, renal failure, congestive heart failure, psychoses, metastatic cancer, paralysis, or other neurological disorders were less likely to receive a prescription, as were patients who underwent procedures for acute central nervous system disorders, severe renal disease, or serious nutritional compromise. Veterans evaluated initially as more cognitively and physically able had higher likelihood of prosthetic prescription, and those with transtibial amputations had higher likelihood of prosthetic prescription than those with transfemoral amputations.
CONCLUSION: Amputees aged 75 and older are less likely to receive a prosthetic limb prescription than younger individuals, even after controlling for comorbidities and functional status. Findings support the PAQ framework, in which contexts, etiologies, anatomic level, comorbidities, medical acuity, and initial function are determinants of outcome. Medical and functional conditions that adversely affect level of energy, ability to move independently, or ability to exercise judgment reduce the likelihood of prosthetic prescription.

Entities:  

Mesh:

Year:  2007        PMID: 17537091      PMCID: PMC3700729          DOI: 10.1111/j.1532-5415.2007.01187.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  24 in total

1.  Success rates for rehabilitation of vascular amputees: implications for preoperative assessment and amputation level.

Authors:  A D Houghton; P R Taylor; S Thurlow; E Rootes; I McColl
Journal:  Br J Surg       Date:  1992-08       Impact factor: 6.939

2.  The Functional Independence Measure: tests of scaling assumptions, structure, and reliability across 20 diverse impairment categories.

Authors:  M G Stineman; J A Shea; A Jette; C J Tassoni; K J Ottenbacher; R Fiedler; C V Granger
Journal:  Arch Phys Med Rehabil       Date:  1996-11       Impact factor: 3.966

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

4.  Rehabilitation outcome 5 years after 100 lower-limb amputations.

Authors:  D L McWhinnie; A C Gordon; J Collin; D W Gray; J D Morrison
Journal:  Br J Surg       Date:  1994-11       Impact factor: 6.939

5.  Risk factors associated with mortality in veteran population following transtibial or transfemoral amputation.

Authors:  Barbara Bates; Margaret G Stineman; Dean M Reker; Jibby E Kurichi; Pui L Kwong
Journal:  J Rehabil Res Dev       Date:  2006 Nov-Dec

6.  Use of lower limb prosthesis among elderly amputees.

Authors:  K M Chan; E S Tan
Journal:  Ann Acad Med Singapore       Date:  1990-11       Impact factor: 2.473

7.  Enabling factors related to prosthetic use by people with transtibial and transfemoral amputation.

Authors:  C Gauthier-Gagnon; M C Grisé; D Potvin
Journal:  Arch Phys Med Rehabil       Date:  1999-06       Impact factor: 3.966

8.  Interrater reliability of the 7-level functional independence measure (FIM)

Authors:  B B Hamilton; J A Laughlin; R C Fiedler; C V Granger
Journal:  Scand J Rehabil Med       Date:  1994-09

9.  Rehabilitation after amputation for vascular disease: a follow-up study.

Authors:  N De Luccia; M A Pinto; J P Guedes; M T Albers
Journal:  Prosthet Orthot Int       Date:  1992-08       Impact factor: 1.895

10.  Rehabilitation potential of elderly patients with major amputations.

Authors:  K A Harris; L van Schie; S E Carroll; A Deathe; O Maryniak; G E Meads; J P Sweeney
Journal:  J Cardiovasc Surg (Torino)       Date:  1991 Jul-Aug       Impact factor: 1.888

View more
  22 in total

1.  Predictors of Receiving a Prosthesis for Adults With Above-Knee Amputations in a Well-Defined Population.

Authors:  Benjamin F Mundell; Hilal Maradit Kremers; Sue Visscher; Kurtis M Hoppe; Kenton R Kaufman
Journal:  PM R       Date:  2015-12-12       Impact factor: 2.298

2.  [Outcomes of multimorbid vascular surgery patients with and without major amputation in a German geriatric rehabilitation clinic].

Authors:  Stefan Grund; Manuela Mettlach; Meinhard Kieser; Konrad Rath; Hans-Georg Schäfer
Journal:  Z Gerontol Geriatr       Date:  2015-01-23       Impact factor: 1.281

3.  Prognostic differences for functional recovery after major lower limb amputation: effects of the timing and type of inpatient rehabilitation services in the Veterans Health Administration.

Authors:  Margaret G Stineman; Pui L Kwong; Dawei Xie; Jibby E Kurichi; Diane Cowper Ripley; David M Brooks; Douglas E Bidelspach; Barbara E Bates
Journal:  PM R       Date:  2010-04       Impact factor: 2.298

4.  Predicting successful prosthetic rehabilitation in major lower-limb amputation patients: a 15-year retrospective cohort study.

Authors:  Inés Fajardo-Martos; Olga Roda; Ramón Zambudio-Periago; Aurora Bueno-Cavanillas; Fidel Hita-Contreras; Indalecio Sánchez-Montesinos
Journal:  Braz J Phys Ther       Date:  2017-11-07       Impact factor: 3.377

5.  Patient-, treatment-, and facility-level structural characteristics associated with the receipt of preoperative lower extremity amputation rehabilitation.

Authors:  Barbara E Bates; Richard Hallenbeck; Toni Ferrario; Pui L Kwong; Jibby E Kurichi; Margaret G Stineman; Dawei Xie
Journal:  PM R       Date:  2012-08-30       Impact factor: 2.298

6.  Changes in cognitive function from presurgery to 4 months postsurgery in individuals undergoing dysvascular amputation.

Authors:  Rhonda M Williams; Aaron P Turner; Monica Green; Daniel C Norvell; Alison W Henderson; Kevin N Hakimi; Donna J Blake; Joseph M Czerniecki
Journal:  Arch Phys Med Rehabil       Date:  2013-12-04       Impact factor: 3.966

7.  Factors influencing receipt of outpatient rehabilitation services among veterans following lower extremity amputation.

Authors:  Jianxun Zhou; Barbara E Bates; Jibby E Kurichi; Pui L Kwong; Dawei Xie; Margaret G Stineman
Journal:  Arch Phys Med Rehabil       Date:  2011-09       Impact factor: 3.966

8.  Possible incremental benefits of specialized rehabilitation bed units among veterans after lower extremity amputation.

Authors:  Jibby E Kurichi; Dylan S Small; Barbara E Bates; Janet A Prvu-Bettger; Pui L Kwong; W Bruce Vogel; Douglas E Bidelspach; Margaret G Stineman
Journal:  Med Care       Date:  2009-04       Impact factor: 2.983

9.  Factors influencing decisions to admit patients to veterans affairs specialized rehabilitation units after lower-extremity amputation.

Authors:  Barbara E Bates; Pui L Kwong; Jibby E Kurichi; Douglas E Bidelspach; Dean M Reker; Greg Maislin; Dawei Xie; Margaret Stineman
Journal:  Arch Phys Med Rehabil       Date:  2009-12       Impact factor: 3.966

10.  Factors associated with home discharge after rehabilitation among male veterans with lower extremity amputation.

Authors:  Jibby E Kurichi; Diane Cowper Ripley; Dawei Xie; Pui L Kwong; Barbara E Bates; Margaret G Stineman
Journal:  PM R       Date:  2012-11-14       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.